AdaptHealth Corp. (NASDAQ:AHCO) Shares Purchased by Federated Hermes Inc.

Federated Hermes Inc. lifted its stake in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 672.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 705,125 shares of the company's stock after purchasing an additional 613,882 shares during the quarter. Federated Hermes Inc. owned about 0.52% of AdaptHealth worth $5,140,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Deerfield Management Company L.P. Series C raised its position in AdaptHealth by 22.7% in the third quarter. Deerfield Management Company L.P. Series C now owns 13,607,940 shares of the company's stock worth $123,832,000 after acquiring an additional 2,513,026 shares in the last quarter. Kennedy Capital Management LLC increased its stake in AdaptHealth by 149.3% in the 3rd quarter. Kennedy Capital Management LLC now owns 1,483,640 shares of the company's stock worth $13,501,000 after purchasing an additional 888,504 shares in the last quarter. Loomis Sayles & Co. L P purchased a new position in AdaptHealth in the 3rd quarter worth about $5,751,000. Reinhart Partners LLC. increased its stake in AdaptHealth by 18.7% in the 3rd quarter. Reinhart Partners LLC. now owns 3,622,177 shares of the company's stock worth $32,962,000 after purchasing an additional 570,497 shares in the last quarter. Finally, LGT Capital Partners LTD. increased its stake in AdaptHealth by 79.4% in the 4th quarter. LGT Capital Partners LTD. now owns 1,000,000 shares of the company's stock worth $7,290,000 after purchasing an additional 442,500 shares in the last quarter. 82.67% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, major shareholder James E. Flynn sold 182,607 shares of the business's stock in a transaction that occurred on Monday, March 11th. The stock was sold at an average price of $11.02, for a total value of $2,012,329.14. Following the completion of the sale, the insider now directly owns 11,643,769 shares in the company, valued at approximately $128,314,334.38. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, major shareholder James E. Flynn sold 182,607 shares of the company's stock in a transaction that occurred on Monday, March 11th. The stock was sold at an average price of $11.02, for a total transaction of $2,012,329.14. Following the completion of the transaction, the insider now directly owns 11,643,769 shares in the company, valued at $128,314,334.38. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, major shareholder James E. Flynn sold 52,487 shares of the company's stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $10.93, for a total value of $573,682.91. Following the transaction, the insider now owns 11,826,376 shares of the company's stock, valued at $129,262,289.68. The disclosure for this sale can be found here. Corporate insiders own 13.60% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on AHCO shares. UBS Group lifted their target price on AdaptHealth from $9.00 to $13.00 and gave the company a "buy" rating in a research note on Wednesday, February 28th. Truist Financial lifted their target price on AdaptHealth from $11.00 to $13.00 and gave the company a "buy" rating in a research note on Wednesday, February 28th. Jefferies Financial Group cut AdaptHealth from a "buy" rating to a "hold" rating and lowered their target price for the company from $14.50 to $8.00 in a research note on Monday, January 8th. Finally, Royal Bank of Canada reaffirmed an "outperform" rating and set a $13.00 target price on shares of AdaptHealth in a research note on Monday, March 4th. One analyst has rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $12.10.

AdaptHealth Stock Up 4.0 %

Shares of NASDAQ AHCO traded up $0.38 during trading hours on Friday, hitting $9.96. The stock had a trading volume of 1,053,761 shares, compared to its average volume of 1,082,691. The company has a market capitalization of $1.32 billion, a P/E ratio of -1.88, a P/E/G ratio of 0.64 and a beta of 1.02. The firm's 50-day moving average price is $10.05 and its two-hundred day moving average price is $8.44. AdaptHealth Corp. has a 52 week low of $6.37 and a 52 week high of $15.37. The company has a debt-to-equity ratio of 1.44, a quick ratio of 1.00 and a current ratio of 1.21.

AdaptHealth (NASDAQ:AHCO - Get Free Report) last announced its quarterly earnings results on Tuesday, February 27th. The company reported $0.64 EPS for the quarter, beating the consensus estimate of $0.20 by $0.44. AdaptHealth had a positive return on equity of 8.84% and a negative net margin of 21.21%. The business had revenue of $858.23 million during the quarter, compared to analysts' expectations of $825.94 million. Analysts anticipate that AdaptHealth Corp. will post 0.88 EPS for the current fiscal year.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.